Otoscan, our digital ear scanning product, continued its ramp up contributing to growth in our audiology market. Natus continues to lead the neuro diagnostic device market with Q2 year-to-date revenue growth of approximately 8%. EMG and other neuro device sales also contributed to the revenue growth, but revenue from our neurosurgery products declined 6% during the quarter offsetting some of the growth from neurodiagnostics. Revenue growth from our neuro market was driven by strong sales of our neuro EEG devices both in the United States and international markets. Revenue for the quarter was $125.4 million, achieving the higher end of our guidance expectations. Today, we reported our financial results for the second quarter of 2019. I would now like to turn the call over to Jonathan Kennedy, President and Chief Executive Officer of Natus Medical. For a description of relevant risks and uncertainties pertaining to our business, please see today’s press release and our periodic and annual reports filed with the SEC. Our actual results may differ materially from these forward-looking statements. These statements include management’s beliefs and expectations about our future results. Today’s call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Finally, we will open the call for your questions.
#Natus baby full
Then Drew will discuss the second quarter financial performance and provide guidance for the third quarter and full year 2019. Jonathan will begin today with a business overview of the second quarter 2019. On the call today from Natus is Jonathan Kennedy, Natus President and Chief Executive Officer and Drew Davies, Natus Executive Vice President and Chief Financial Officer. Good afternoon and thank you for joining us today to review our results for the Second Quarter of 2019. Jonathan Kennedy - President and Chief Executive Officerĭrew Davies - Executive Vice President and Chief Financial Officer Each model provides a safe and accurate way to measure newborn weight.Natus Medical Incorporated ( BABY) Q2 2019 Earnings Conference Call J4:30 PM ET Olympic Smart Scales is available in two models: Smart Scale® tabletop Model 60 and Smart Scale® roll-around cart combination Model 65. The design of the tray includes four raised sides that are safer for the newborn while making it easier for the care provider to lift the child in and out. A memory recall button allows the last averaged weight to appear on the display, even if the scale has been turned off. When the scale detects motion, it automatically averages and computes within seconds, locking in the final weight. Designed for active newborns and growing babies up to 15,000 grams (33 pounds). The result remains locked on the display. The zero (tare) button even lets you cancel out extra weight for additional items, such as blankets or toys. The final weight is automatically locked on the display, making it possible to continue providing care and charting the results.Įach scale automatically zeros itself before weighing, ensuring accurate measurements are taken. The Olympic Smart Scale is ideal for newborns, providing a stable weight display even when the child is active.
The Olympic Smart Scale from Natus is an important tool to help track the growth and development of every newborn. A newborn’s weight is a good indicator of the overall health of a child.
0 kommentar(er)
